ASIA PACIFIC METABOLOMICS MARKET FORECAST 2019-2027

  • You are here:
  • Home
  • Reports
  • ASIA PACIFIC METABOLOMICS MARKET FORECAST 2019-2027

ASIA PACIFIC METABOLOMICS MARKET FORECAST 2019-2027

The Asia Pacific metabolomics market is estimated to record substantial growth at a CAGR of 12.33% during the projected period. The rising adoption of modern and nonconventional therapeutic procedures in the region is the most prominent reason driving the market growth of the region. The metabolomics market in the Asia Pacific region is segmented into the regions of China, Japan, Australia, South Korea, India, and the Rest of Asia Pacific. The conducive market environment of the region is resulting in the emergence of ample growth opportunities for growth opportunities. The countries like India are witnessing mergers and collaborations between different government bodies in terms of R&D activities, with regard to metabolomics.

ASIA PACIFIC METABOLOMICS MARKET FORECAST 2019-2027

Request free sample

The Asia Pacific metabolomics market is estimated to record substantial growth at a CAGR of 12.33% during the projected period. The rising adoption of modern and nonconventional therapeutic procedures in the region is the most prominent reason driving the market growth of the region.

The metabolomics market in the Asia Pacific region is segmented into the regions of China, Japan, Australia, South Korea, India, and the Rest of Asia Pacific. The conducive market environment of the region is resulting in the emergence of ample growth opportunities for growth opportunities. The countries like India are witnessing mergers and collaborations between different government bodies in terms of R&D activities, with regard to metabolomics. Also, there have been increasing investments from both, private and public organizations. These factors are projected to impact the metabolomics market growth in India in a positive manner. The investments are proving to be significant in order to ignite the collective efforts of industries, academia, and national research laboratories, together. This will further aid in the high growth of the market in the region during the forecasted period. There has been increasing expenditure on the healthcare sector in regions like Australia. Moreover, Australia boasts of well-established infrastructure facilities and increasing access to high-end technology in several off its sectors. Thus, these factors are projected to boost the market growth of metabolomics in Australia.

The strategic initiatives by the players of the market are estimated to have immense impacts on the growth and revenue of the market. One of the eminent companies in the market is the Apical Scientific SDN BHD. The company provides its services in the Asia Pacific region. The product portfolio includes, next-generation sequencing, DNA and RNA synthesis, etc.

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP-DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • METABOLOMICS BIOINFORMATICS TOOLS AND SERVICES ARE THE FASTEST GROWING PRODUCT & SERVICE
      • BIOMARKER DISCOVERY IS THE WIDELY USED APPLICATION
      • CANCER IS THE MOST PREVALENT INDICATION
  1. MARKET DYNAMICS
    • MARKET SCOPE & DEFINITION
    • MARKET DRIVERS
      • GROWING INVESTMENTS IN THE METABOLOMICS DOMAIN BY THE PUBLIC AND PRIVATE SECTORS
      • RISE IN THE DEMAND FOR PERSONALIZED MEDICINES
      • UPSURGE IN THE INCIDENCES OF CHRONIC DISEASE
    • MARKET RESTRAINTS
      • LACK OF SKILLED PROFESSIONALS IN METABOLOMICS
      • HIGH COST OF THE INSTRUMENTS
    • MARKET OPPORTUNITIES
      • EMERGING APPLICATION OF METABOLOMICS IN HUMAN NUTRITION
      • GROWING USAGES IN THE EARLY DETECTION OF CHRONIC DISEASES
    • MARKET CHALLENGES
      • COMPLEX AND DIVERSE NATURE OF THE BIOLOGICAL SAMPLES
  1. MARKET BY PRODUCT & SERVICE
    • METABOLOMICS INSTRUMENTS
      • SEPARATION TECHNIQUE
      • DETECTION TECHNIQUE
    • METABOLOMICS BIOINFORMATICS TOOLS AND SERVICES
  2. MARKET BY APPLICATION
    • BIOMARKER DISCOVERY
    • DRUG DISCOVERY
    • TOXICOLOGY TESTING
    • NUTRIGENOMICS
    • FUNCTIONAL GENOMICS
    • PERSONALIZED MEDICINE
    • OTHER APPLICATION
  3. MARKET BY INDICATION
    • CANCER
    • CARDIOVASCULAR DISORDERS
    • NEUROLOGICAL DISORDERS
    • INBORN ERRORS OF METABOLISM
    • OTHER INDICATION
  4. KEY ANALYTICS
    • PORTER’S FIVE FORCES MODEL
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTE
      • BARGAINING POWER OF BUYERS
      • BARGAINING POWER OF SUPPLIERS
      • THREAT OF COMPETITIVE RIVALRY
    • VALUE CHAIN ANALYSIS
    • MARKET TRENDS
    • OPPORTUNITY MATRIX
  5. GEOGRAPHICAL ANALYSIS
    • ASIA PACIFIC
      • JAPAN
      • CHINA
      • AUSTRALIA
      • INDIA
      • SOUTH KOREA
      • REST OF ASIA PACIFIC
  1. COMPETITIVE LANDSCAPE
    • MARKET POSITION ANALYSIS
    • COMPANY PROFILES
      • AGILENT TECHNOLOGIES, INC.
      • APICAL SCIENTIFIC SDN BHD
      • BIOCRATES LIFE SCIENCES AG
      • BIO-RAD LABORATORIES, INC.
      • BRUKER CORPORATION
      • CREATIVE PROTEOMICS
      • DANAHER CORPORATION (SCIEX)
      • HUMAN METABOLOME TECHNOLOGIES, INC.
      • KORE TECHNOLOGY LIMITED
      • LECO CORPORATION
      • METABOLON INC.
      • PERKINELMER, INC.
      • SHIMADZU CORPORATION
      • THERMO FISHER SCIENTIFIC INC.
      • WATERS CORPORATION

 

TABLE LIST

TABLE 1: ASIA PACIFIC METABOLOMICS MARKET, 2019-2027 ($ MILLION)

TABLE 2: ASIA PACIFIC METAGENOMICS MARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)

TABLE 3: ASIA PACIFIC METABOLOMICS INSTRUMENTS MARKET, 2019-2027 ($ MILLION)

TABLE 4: ASIA PACIFIC METABOLOMICS INSTRUMENTS MARKET, BY TYPE, 2019-2027 ($ MILLION)

TABLE 5: ASIA PACIFIC SEPARATION TECHNIQUE MARKET, 2019-2027 ($ MILLION)

TABLE 6: ASIA PACIFIC DETECTION TECHNIQUE MARKET, 2019-2027 ($ MILLION)

TABLE 7: ASIA PACIFIC METABOLOMICS BIOINFORMATICS TOOLS AND SERVICES MARKET, 2019-2027 ($ MILLION)

TABLE 8: ASIA PACIFIC METABOLOMICS MARKET, BY APPLICATION, 2019-2027 ($ MILLION)

TABLE 9: ASIA PACIFIC BIOMARKER DISCOVERY MARKET, 2019-2027 ($ MILLION)

TABLE 10: ASIA PACIFIC DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)

TABLE 11: ASIA PACIFIC TOXICOLOGY TESTING MARKET, 2019-2027 ($ MILLION)

TABLE 12: ASIA PACIFIC NUTRIGENOMICS MARKET, 2019-2027 ($ MILLION)

TABLE 13: ASIA PACIFIC FUNCTIONAL GENOMICS MARKET, 2019-2027 ($ MILLION)

TABLE 14: ASIA PACIFIC PERSONALIZED MEDICINE MARKET, 2019-2027 ($ MILLION)

TABLE 15: ASIA PACIFIC OTHER APPLICATION MARKET, 2019-2027 ($ MILLION)

TABLE 16: ASIA PACIFIC METABOLOMICS MARKET, BY INDICATION, 2019-2027 ($ MILLION)

TABLE 17: ASIA PACIFIC CANCER MARKET, 2019-2027 ($ MILLION)

TABLE 18: ASIA PACIFIC CARDIOVASCULAR DISORDERS MARKET, 2019-2027 ($ MILLION)

TABLE 19: ASIA PACIFIC NEUROLOGICAL DISORDERS MARKET, 2019-2027 ($ MILLION)

TABLE 20: ASIA PACIFIC INBORN ERRORS OF METABOLISM MARKET, 2019-2027 ($ MILLION)

TABLE 21: ASIA PACIFIC OTHER INDICATION MARKET, 2019-2027 ($ MILLION)

TABLE 22: ASIA PACIFIC METABOLOMIC SMARKET, BY COUNTRY, 2019-2027 ($ MILLION)

TABLE 23: JAPAN METABOLOMICS MARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)

TABLE 24: JAPAN METABOLOMICS MARKET, BY APPLICATION, 2019-2027 ($ MILLION)

TABLE 25: JAPAN METABOLOMICS MARKET, BY INDICATION, 2019-2027 ($ MILLION)

TABLE 26: CHINA METABOLOMICS MARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)

TABLE 27: CHINA METABOLOMICS MARKET, BY APPLICATION, 2019-2027 ($ MILLION)

TABLE 28: CHINA METABOLOMICS MARKET, BY INDICATION, 2019-2027 ($ MILLION)

TABLE 29: AUSTRALIA METABOLOMICS MARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)

TABLE 30: AUSTRALIA METABOLOMICS MARKET, BY APPLICATION, 2019-2027 ($ MILLION)

TABLE 31: AUSTRALIA METABOLOMICS MARKET, BY INDICATION, 2019-2027 ($ MILLION)

TABLE 32: INDIA METABOLOMICS MARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)

TABLE 33: INDIA METABOLOMICS MARKET, BY APPLICATION, 2019-2027 ($ MILLION)

TABLE 34: INDIA METABOLOMICS MARKET, BY INDICATION, 2019-2027 ($ MILLION)

TABLE 35: SOUTH KOREA METABOLOMICS MARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)

TABLE 36: SOUTH KOREA METABOLOMICS MARKET, BY APPLICATION, 2019-2027 ($ MILLION)

TABLE 37: SOUTH KOREA METABOLOMICS MARKET, BY INDICATION, 2019-2027 ($ MILLION)

TABLE 38: METABOLOMICS COMPANY MARKET POSITION ANALYSIS, 2018

FIGURE LIST 

FIGURE 1: ASIA PACIFIC METABOLOMICS MARKET, 2019-2027 ($ MILLION)

FIGURE 2: ASIA PACIFIC METAGENOMICS MARKET, BY METABOLOMICS INSTRUMENTS, 2019-2027 ($ MILLION)

FIGURE 3: ASIA PACIFIC METABOLOMICS INSTRUMENTS MARKET, BY SEPARATION TECHNIQUE, 2019-2027 ($ MILLION)

FIGURE 4: ASIA PACIFIC METABOLOMICS INSTRUMENTS MARKET, BY DETECTION TECHNIQUE, 2019-2027 ($ MILLION)

FIGURE 5: ASIA PACIFIC METAGENOMICS MARKET, BY METABOLOMICS BIOINFORMATICS TOOLS AND SERVICES, 2019-2027 ($ MILLION)

FIGURE 6: ASIA PACIFIC METABOLOMICS MARKET, BY BIOMARKER DISCOVERY, 2019-2027 ($ MILLION)

FIGURE 7: ASIA PACIFIC METABOLOMICS MARKET, BY DRUG DISCOVERY, 2019-2027 ($ MILLION)

FIGURE 8: ASIA PACIFIC METABOLOMICS MARKET, BY TOXICOLOGY TESTING, 2019-2027 ($ MILLION)

FIGURE 9: ASIA PACIFIC METABOLOMICS MARKET, BY NUTRIGENOMICS, 2019-2027 ($ MILLION)

FIGURE 10: ASIA PACIFIC METABOLOMICS MARKET, BY FUNCTIONAL GENOMICS, 2019-2027 ($ MILLION)

FIGURE 11: ASIA PACIFIC METABOLOMICS MARKET, BY PERSONALIZED MEDICINE, 2019-2027 ($ MILLION)

FIGURE 12: ASIA PACIFIC METABOLOMICS MARKET, BY OTHER APPLICATION, 2019-2027 ($ MILLION)

FIGURE 13: ASIA PACIFIC METABOLOMICS MARKET, BY CANCER, 2019-2027 ($ MILLION)

FIGURE 14: ASIA PACIFIC METABOLOMICS MARKET, BY CARDIOVASCULAR DISORDERS, 2019-2027 ($ MILLION)

FIGURE 15: ASIA PACIFIC METABOLOMICS MARKET, BY NEUROLOGICAL DISORDERS, 2019-2027 ($ MILLION)

FIGURE 16: ASIA PACIFIC METABOLOMICS MARKET, BY INBORN ERRORS OF METABOLISM, 2019-2027 ($ MILLION)

FIGURE 17: ASIA PACIFIC METABOLOMICS MARKET, BY OTHER INDICATION, 2019-2027 ($ MILLION)

FIGURE 18: PORTER’S FIVE FORCE MODEL

FIGURE 19: JAPAN METABOLOMICS MARKET, 2019-2027 ($ MILLION)

FIGURE 20: CHINA METABOLOMICS MARKET, 2019-2027 ($ MILLION)

FIGURE 21: AUSTRALIA METABOLOMICS MARKET, 2019-2027 ($ MILLION)

FIGURE 22: INDIA METABOLOMICS MARKET, 2019-2027 ($ MILLION)

FIGURE 23: SOUTH KOREA METABOLOMICS MARKET, 2019-2027 ($ MILLION)

FIGURE 24: REST OF ASIA PACIFIC METABOLOMICS MARKET, 2019-2027 ($ MILLION)

  1. GEOGRAPHICAL ANALYSIS
    • ASIA PACIFIC
      • JAPAN
      • CHINA
      • AUSTRALIA
      • INDIA
      • SOUTH KOREA
      • REST OF ASIA PACIFIC
  1. MARKET BY PRODUCT & SERVICE
    • METABOLOMICS INSTRUMENTS
      • SEPARATION TECHNIQUE
      • DETECTION TECHNIQUE
    • METABOLOMICS BIOINFORMATICS TOOLS AND SERVICES
  2. MARKET BY APPLICATION
    • BIOMARKER DISCOVERY
    • DRUG DISCOVERY
    • TOXICOLOGY TESTING
    • NUTRIGENOMICS
    • FUNCTIONAL GENOMICS
    • PERSONALIZED MEDICINE
    • OTHER APPLICATION
  3. MARKET BY INDICATION
    • CANCER
    • CARDIOVASCULAR DISORDERS
    • NEUROLOGICAL DISORDERS
    • INBORN ERRORS OF METABOLISM
    • OTHER INDICATION

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now